Note: Ingredients listed on restricted chemical lists
General Information
Version
2022-1
Revision date
2022-01-01
Product name
Enroquin (enrofloxacin) Antibacterial Injectable Solution 2.27%
Product name
Enroquin (enrofloxacin) Antibacterial Injectable Solution 2.27%
Identification on the label/Trade name
Not available
Product Synonyms
Not available
1.2.1 Relevant identified uses
For the management of diseases in dogs associated with bacteria susceptible to enrofloxacin. For professional use only. Federal (U.S.A.) law restricts this drug to be used by or on the order of a licensed veterinarian
Icons in SDS
Company Information
company name
Dechra Veterinary Products
Section 2
SECTION 2: Hazards identification
Classification (GHS-US) Classification of the substance or mixture Classification (GHS-US) This product is a drug, as defined by the US Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.). It is an injectable solution for direct administration to the patient. Therefore, it is exempt from the US 2012 Hazard Communication Standard, as defined in the 29 CFR 1910.1200(b)(6)(vii)
2.2 Label elements
No labeling applicable
2.3 Other hazards
No additional information available
Ingredient(s) with unknown acute toxicity
No data available
2.1 Classification of the substance or mixture
Classification (GHS-US) This product is a drug, as defined by the US Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.). It is an injectable solution for direct administration to the patient. Therefore, it is exempt from the US 2012 Hazard Communication Standard, as defined in the 29 CFR 1910.1200(b)(6)(vii).
